Return to Listing

1 result(s) for Nivolumab

PI Name Protocol # Title
Matthew Taylor IRB00009902 A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080